Yucatan, First National Place in Maternal Morbidity Due to Hypertensive Disease: Experience Analysis
Background: Hypertensive disorders increase maternal-fetal morbidity and mortality.In Mexico, hypertensive disease is the main predictor of maternal morbidity (62.7%) (1).According to the National Epidemiological Surveillance System, the states with the highest maternal morbidity rates are Yucatn (30.2),Jalisco (20.8), and Guerrero (14.2).Yucatn ranks first nationally in maternal morbidity but is among the states with the lowest obstetric severity index (1.69%),indicating success in risk identification, diagnosis, and management.Objective: To determine the prevalence of hypertensive disorders during pregnancy, associated risk factors, and morbidity.Methods: Observational, retrospective, and descriptive study.Review of medical records of patients diagnosed with hypertensive disorders and meeting criteria for severe maternal morbidity, between June 1, 2019, and January 1, 2025.Results: Total of 1,842 patients were included.Mean age: 26.3 years.Median number of pregnancies: 3; deliveries: 2; abortions: 1; cesarean sections: 1.5.Average gestational age at diagnosis: 31.5 weeks.Recurrence of hypertensive disease in previous pregnancy with severe preeclampsia: 62%.Associated morbidity in 82% of patients.Risk factors: previous pregnancy with preeclampsia (OR 12.949) and obesity (OR 1.828, p = 0.029).Conclusion: Accurate detection of complications associated with hypertensive disorders highlights the importance of prevention, early diagnosis, and timely treatment as key strategies to reduce maternal morbidity.
Authors
- J Cabrera
- A. López (ORCID: https://orcid.org/0000-0003-1877-8964)
- María Mercedes Ávila (ORCID: https://orcid.org/0000-0002-4746-4473)
- Gustavo Sierra (ORCID: https://orcid.org/0009-0009-2351-2758)
Publication Details
- Journal
- Mathews Journal of Gynecology & Obstetrics
- Published
- 2025-07-15
- DOI
- https://doi.org/10.30654/mjgo.10048
- Primary Topic
- Maternal and Neonatal Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00